{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:55:41Z","timestamp":1790193341593,"version":"4.1.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Recent years have seen a dramatic increase in the identification of autoimmune encephalitis (AE) and the emergence of new causes of infectious encephalitis (IE). However, management of these patients remains challenging, with many requiring care in intensive care units. Here, we describe recent advances in the diagnosis and management of acute encephalitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Advances in the identification of clinical presentations, neuroimaging biomarkers, and electroencephalogram patterns have enabled more rapid diagnosis of encephalitis. Newer modalities such as meningitis\/encephalitis multiplex PCR panels, metagenomic next-generation sequencing, and phage display-based assays are being evaluated in an effort to improve detection of autoantibodies and pathogens. Specific advances in the treatment of AE include establishment of a systematic approach to first-line therapies and the development of newer second-line modalities. The role of immunomodulation and its applications in IE are actively being investigated. In the ICU, particular attention to status epilepticus, cerebral edema, and dysautonomia may improve outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Substantial diagnostic delays still occur, with many cases left without an identified etiology. Antiviral therapies remain scarce, and optimal treatment regimens for AE still need to be clarified. Nevertheless, our understanding of diagnostic and therapeutic approaches to encephalitis is rapidly evolving.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcc.0000000000001028","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T09:00:41Z","timestamp":1676538041000},"page":"89-98","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Approach to acute encephalitis in the intensive care unit"],"prefix":"10.1097","volume":"29","author":[{"given":"Arun","family":"Venkatesan","sequence":"first","affiliation":[{"name":"Johns Hopkins Encephalitis Center, Department of Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Habis","sequence":"additional","affiliation":[{"name":"Johns Hopkins Encephalitis Center, Department of Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romergryko G.","family":"Geocadin","sequence":"additional","affiliation":[{"name":"Johns Hopkins Encephalitis Center, Department of Neurology"},{"name":"Departments of Neurosurgery and Anaesthesia\/Critical Care, Johns Hopkins University School of Medicine, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"e2540","DOI":"10.1002\/brb3.2540","article-title":"Outcome of neurocritical disorders, a multicenter prospective cross-sectional study","volume":"12","author":"Ali","year":"2022","journal-title":"Brain Behav"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(18)32526-1","article-title":"Acute encephalitis in immunocompetent adults","volume":"393","author":"Venkatesan","year":"2019","journal-title":"Lancet"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"2832418","DOI":"10.1155\/2020\/2832418","article-title":"Predictors of outcome in clinically diagnosed viral encephalitis patients: a 5-year prospective study","volume":"2020","author":"Feng","year":"2020","journal-title":"BioMed Res Int"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"890656","DOI":"10.3389\/fimmu.2022.890656","article-title":"Clinical features, treatment, and prognostic factors in neuronal surface antibody-mediated severe autoimmune encephalitis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann Neurol"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3390\/brainsci12091130","article-title":"Autoimmune encephalitis: a physician's guide to the clinical spectrum diagnosis and management","volume":"12","author":"Patel","year":"2022","journal-title":"Brain Sci"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"607773","DOI":"10.3389\/fneur.2021.607773","article-title":"An Australian state-based cohort study of autoimmune encephalitis cases detailing clinical presentation, investigation results, and response to therapy","volume":"12","author":"Swayne","year":"2021","journal-title":"Front Neurol"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"621599","DOI":"10.3389\/fimmu.2021.621599","article-title":"Neuronal surface antibody-medicated autoimmune encephalitis (limbic encephalitis) in china: a multiple-center, retrospective study","volume":"12","author":"Shan","year":"2021","journal-title":"Front Immunol"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1093\/brain\/awac166","article-title":"Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes","volume":"145","author":"Lee","year":"2022","journal-title":"Brain"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idnow.2021.11.007","article-title":"Changing profile of encephalitis: results of a 4-year study in France","volume":"52","author":"Mailles","year":"2022","journal-title":"Infect Dis Now"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"101972","DOI":"10.1016\/j.ttbdis.2022.101972","article-title":"The epidemiology of infectious diseases in Europe in 2020 versus 2017\u20132019 and the rise of tick-borne encephalitis (1995\u20132020)","volume":"13","author":"Jenkins","year":"2022","journal-title":"Ticks Tick-borne Dis"},{"key":"R15-20250729","first-page":"e26264","article-title":"Neuroinvasive West Nile Virus (WNV) encephalitis with anton syndrome: epidemiology and pathophysiology review","volume":"14","author":"Srichawla","year":"2022","journal-title":"Cureus"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/cid\/cit458","article-title":"Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium","volume":"57","author":"Venkatesan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-3-030-36548-6_17","article-title":"Autoimmune encephalitis in the intensive care unit","volume":"2020","author":"Diaz-Arias","year":"2020","journal-title":"Curr Clin Neurol"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/NDT.S292343","article-title":"Clinical features and long-term outcomes of anti-leucine-rich glioma-inactivated 1 encephalitis: a multi-center study","volume":"17","author":"Qiao","year":"2021","journal-title":"Neuropsychiatr Dis Treatm"},{"key":"R19-20250729","first-page":"ciac711","article-title":"Development and validation of a risk score to differentiate viral and autoimmune encephalitis in adults","volume":"2022","author":"Granillo","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1212\/CON.0000000000001006","article-title":"Encephalitis and brain abscess","volume":"27","author":"Venkatesan","year":"2021","journal-title":"CONTINUUM: Lifelong Learn Neurol"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"e2114328","DOI":"10.1001\/jamanetworkopen.2021.14328","article-title":"Assessment of magnetic resonance imaging changes and functional outcomes among adults with severe herpes simplex encephalitis","volume":"4","author":"Sarton","year":"2021","journal-title":"JAMA Network Open"},{"key":"R23-20250729","first-page":"e244","article-title":"A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis","volume":"92","author":"Balu","year":"2018","journal-title":"Neurology"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinimag.2021.12.011","article-title":"Brain on fire: an imaging-based review of autoimmune encephalitis","volume":"84","author":"Ball","year":"2022","journal-title":"Clin Imaging"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"e1158","DOI":"10.1212\/NXI.0000000000001158","article-title":"MRI characteristics of autoimmune encephalitis with autoantibodies to GABAA receptor","volume":"9","author":"Deng","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s00259-021-05299-y","article-title":"Brain 18F-FDG PET for the diagnosis of autoimmune encephalitis: a systematic review and a meta-analysis","volume":"48","author":"Bordonne","year":"2021","journal-title":"Eur J Nuclear Med Mol Imaging"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"e0227906","DOI":"10.1371\/journal.pone.0227906","article-title":"18F-FDG-PET\/MRI in the diagnostic work-up of limbic encephalitis","volume":"15","author":"Deuschl","year":"2020","journal-title":"PLoS One"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"672846","DOI":"10.3389\/fimmu.2021.672846","article-title":"Subcortical hypermetabolism associated with cortical hypometabolism is a common metabolic pattern in patients with anti-leucine-rich glioma-inactivated 1 antibody encephalitis","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Immunol"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1212\/NXI.0000000000000413","article-title":"Decreased occipital lobe metabolism by FDG-PET\/CT","volume":"5","author":"Probasco","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s13760-021-01771-6","article-title":"Interhemispheric metabolic asymmetries in patients with anti-NMDA receptor encephalitis","volume":"121","author":"Serrien","year":"2021","journal-title":"Acta Neurologica Belgica"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"115571","DOI":"10.1016\/j.diagmicrobio.2021.115571","article-title":"Evaluation of the selection of cerebrospinal fluid testing in suspected meningitis and encephalitis","volume":"102","author":"Morrison","year":"2022","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"e0277421","DOI":"10.1128\/spectrum.02774-21","article-title":"Differential performance of the FilmArray meningitis\/encephalitis assay to detect bacterial and viral pathogens in both pediatric and adult populations","volume":"10","author":"Schnuriger","year":"2022","journal-title":"Microbiol Spectr"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"101170","DOI":"10.1016\/j.mycmed.2021.101170","article-title":"Evaluation of the BioFire\u00ae FilmArray\u00ae Meningitis\/Encephalitis panel in an adult and pediatric Ugandan population","volume":"31","author":"Bridge","year":"2021","journal-title":"J Med Mycol"},{"key":"R35-20250729","first-page":"1028","article-title":"Assessment of the impact of a meningitis\/encephalitis panel on hospital length of stay: a systematic review and meta-analysis","volume":"11","author":"Hueth","year":"2022","journal-title":"Antibiotics (Basel Switzerland)"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fcimb.2020.00088","article-title":"Metagenomic next-generation sequencing for diagnosis of infectious encephalitis and meningitis: a large, prospective case series of 213 patients","volume":"10","author":"Xing","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"16173","DOI":"10.1038\/s41598-020-73156-3","article-title":"Next-generation sequencing in the diagnosis of viral encephalitis: sensitivity and clinical limitations","volume":"10","author":"Perlejewski","year":"2020","journal-title":"Sci Rep"},{"key":"R38-20250729","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMoa1816721","article-title":"Kelch-like protein 11 antibodies in seminoma-associated paraneoplastic encephalitis","volume":"381","author":"Mandel-Brehm","year":"2019","journal-title":"N Engl J Med"},{"key":"R39-20250729","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neurol.2021.12.002","article-title":"Intensive care management of patients with viral encephalitis","volume":"178","author":"Sonneville","year":"2022","journal-title":"Revue Neurologique"},{"key":"R40-20250729","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.2147\/NDT.S274487","article-title":"Comparisons between infectious and autoimmune encephalitis: clinical signs, biochemistry, blood counts, and imaging findings","volume":"16","author":"Huang","year":"2020","journal-title":"Neuropsychiatr Dis Treatm"},{"key":"R41-20250729","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/1550059419868919","article-title":"Electroencephalogram and clinical characteristics and correlations in patients with anti-N-methyl-d-aspartate receptor encephalitis","volume":"51","author":"Lin","year":"2019","journal-title":"Clin EEG Neurosci"},{"key":"R42-20250729","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bj.2020.04.002","article-title":"Neurocritical care for anti-NMDA receptor encephalitis","volume":"43","author":"Lin","year":"2020","journal-title":"Biomed J"},{"key":"R43-20250729","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1007\/s00415-021-10447-3","article-title":"Diagnostic yield of cerebrospinal fluid analysis in status epilepticus: an 8-year cohort study","volume":"268","author":"Dittrich","year":"2021","journal-title":"J Neurol"},{"key":"R44-20250729","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/acn3.51137","article-title":"Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABAB R encephalitis","volume":"7","author":"Shen","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"R45-20250729","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0000000000000151","article-title":"Ketogenic diet for adults in super-refractory status epilepticus","volume":"82","author":"Thakur","year":"2014","journal-title":"Neurology"},{"key":"R46-20250729","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/epi.16571","article-title":"Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: conceptual definitions","volume":"61","author":"Steriade","year":"2020","journal-title":"Epilepsia"},{"key":"R47-20250729","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4103\/0028-3886.344657","article-title":"Understanding and managing autonomic disorders in the neurocritical care unit: a comprehensive review","volume":"70","author":"Abraham","year":"2022","journal-title":"Neurology (India)"},{"key":"R48-20250729","doi-asserted-by":"crossref","first-page":"609750","DOI":"10.3389\/fneur.2021.609750","article-title":"Clinical study of autonomic dysfunction in patients with anti-NMDA receptor encephalitis","volume":"12","author":"Yan","year":"2021","journal-title":"Front Neurol"},{"key":"R49-20250729","doi-asserted-by":"crossref","first-page":"665183","DOI":"10.3389\/fimmu.2021.665183","article-title":"Paroxysmal sympathetic hyperactivity in severe anti-N-methyl-d-aspartate receptor encephalitis: a single center retrospective observational study","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"R50-20250729","doi-asserted-by":"crossref","first-page":"814673","DOI":"10.3389\/fneur.2022.814673","article-title":"Risk factors and prognosis in patients with anti-N-methyl-D-aspartate receptor encephalitis requiring prolonged mechanical ventilation","volume":"13","author":"Lin","year":"2022","journal-title":"Front Neurol"},{"key":"R52-20250729","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.xphs.2021.01.003","article-title":"Novel insights to enhance therapeutics with acyclovir in the management of herpes simplex encephalitis","volume":"110","author":"Assis","year":"2020","journal-title":"J Pharm Sci"},{"key":"R53-20250729","first-page":"1","article-title":"The role of intravenous immunoglobulins in treatment of viral encephalitis in children","volume":"2","author":"EL-Naby","year":"2020","journal-title":"Neuro Res"},{"key":"R54-20250729","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1007\/s10072-022-05891-6","article-title":"Efficacy and safety of intravenous high-dose immunoglobulin in treatment of the severe form of Japanese encephalitis","volume":"43","author":"Chen","year":"2022","journal-title":"Neurol Sci"},{"key":"R55-20250729","doi-asserted-by":"crossref","first-page":"e041808","DOI":"10.1136\/bmjopen-2020-041808","article-title":"Protocol for DexEnceph: a randomised controlled trial of dexamethasone therapy in adults with herpes simplex virus encephalitis","volume":"11","author":"Whitfield","year":"2021","journal-title":"BMJ Open"},{"key":"R56-20250729","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/QCO.0000000000000546","article-title":"Immune-mediated encephalitis for the infectious disease specialist","volume":"32","author":"Venkatesan","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"R57-20250729","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/jnnp-2021-327302","article-title":"LGI1 antibody encephalitis: acute treatment comparisons and outcome","volume":"93","author":"Rodriguez","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R58-20250729","doi-asserted-by":"crossref","first-page":"104071","DOI":"10.1016\/j.msard.2022.104071","article-title":"First-line immunotherapy of neuronal surface antibody-mediated autoimmune encephalitis: Assessment of therapeutic effectiveness and cost-efficiency","volume":"66","author":"Cai","year":"2022","journal-title":"Multiple Sclerosis Related Disord"},{"key":"R59-20250729","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/acn3.51313","article-title":"Clinical efficacy of plasma exchange in patients with autoimmune encephalitis","volume":"8","author":"Zhang","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"R60-20250729","doi-asserted-by":"crossref","first-page":"e1088","DOI":"10.1212\/NXI.0000000000001088","article-title":"Rituximab treatment and long-term outcome of patients with autoimmune encephalitis: real-world evidence from the GENERATE registry","volume":"8","author":"Thaler","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000001028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T20:09:11Z","timestamp":1753819751000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000001028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000001028","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,13]]}}}